Extra-Pharma SRL
8.7 FTEThe score of Extra-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -82 % Total assets -39 % Headcount (avg FTE) +10 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Extra-Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 97,780 € | ||||
| Equity | 559,094 € | ||||
| Cash | 159,799 € | ||||
| EBITDA | 237,051 € | ||||
| Total assets | €3.06m |
Filed annual accounts
- Year ended 31 Mar 2025filed on 29 Sep 2025
- Year ended 31 Mar 2024filed on 29 Oct 2024
- Year ended 31 Mar 2023filed on 31 Oct 2023
- Year ended 31 Mar 2022filed on 28 Oct 2022
- Year ended 31 Mar 2021filed on 15 Nov 2021
Extra-Pharma's financial analysis
- Solvency18.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Extra-Pharma
Extra-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0467.149.426
- VAT number
- BE0467149426
- Peppol
- Registered · 0208:0467149426 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Oct 1999
- Registered office
- 2950 Kapellen
- Size
- Micro · 8.7 FTE
- Latest accounts
- 2025 · filed on 29 Sep 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Extra-Pharma (SRL) has been based in Kapellen since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 97,780 € and equity of 559,094 €; its revenue is not published. With 8.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 18.2%, below the median of its sector (44.2%).
Companies similar to Extra-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Xpharma Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet €3.07m
- GDK Farma Retail sale of pharmaceutical products Grimbergen · balance sheet €3.07m
- Mouscron Pharma Retail sale of pharmaceutical products Mouscron · balance sheet €3.25m
- E.V.N. Pharma Retail sale of pharmaceutical products Grimbergen · balance sheet €3.28m
- VAN Nuffel - DE Vriendt Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet €2.84m
- Les Pharmacies de Gare Retail sale of pharmaceutical products Brussels · balance sheet €2.73m
- Apotheek Van den Broeck Riet Retail sale of pharmaceutical products Ranst · balance sheet €2.67m
Frequently asked questions about Extra-Pharma
What is the revenue of Extra-Pharma?
Extra-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Extra-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0467149426 for Extra-Pharma, if the company is VAT-registered. Its company number (CBE) is 0467.149.426.
Where is the registered office of Extra-Pharma?
According to the CBE register, the registered office of Extra-Pharma is in 2950 Kapellen.
What is the equity of Extra-Pharma?
At the close of the 2025 financial year, the equity of Extra-Pharma amounts to 559,094 €, a solvency of 18.2% of total assets.
How many people work at Extra-Pharma?
8.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Extra-Pharma?
The register lists 2 active mandates at Extra-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Extra-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →